1,796 material Form 8-K filings that 1,448 companies we cover made with the SEC in May 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Avista Corporation sold two series of first mortgage bonds on May 14, 2026, under a private placement bond purchase agreement, with a further $70.0 million expected in August 2026. At its May 14, 2026 annual meeting, shareholders elected all eleven directors and approved three of four proposals, but did not approve the charter amendment to lower the shareholder approval requirement from 80% to a majority.
Issued $90.0 million of 4.77% first mortgage bonds due 2029 and $70.0 million of 6.10% first mortgage bonds due 2056 on May 14, 2026
Expects to issue an additional $70.0 million of 6.10% bonds in August 2026; proceeds to refinance existing debt and fund utility capital expenditures
Proposal 4 to reduce the approval threshold from 80% to a majority failed; it received 64,317,253 votes for, short of the 80% required
All eleven directors were elected; Deloitte & Touche LLP ratification and the advisory say-on-pay vote were approved
Rapid Micro Biosystems entered into an underwritten offering of about 5 million shares of Class A common stock, including pre-funded warrants, with accompanying Series A and Series B warrants, plus a concurrent sale to directors and officers. The company estimates net proceeds of about $8.9 million for working capital and general corporate purposes. The new shares and warrants add to the number of shares outstanding, which dilutes existing shareholders, while the cash raised supports the company's working capital.
3,581,000 Class A common shares plus pre-funded warrants for up to 1,463,000 shares, sold with warrants at a combined price of $1.955 per share
Series A warrants exercisable at $1.955 and Series B warrants exercisable at $2.340, both exercisable six months after issuance
Estimated net proceeds of about $8.9 million; the offering is expected to close on May 20, 2026
Concurrent sale of 71,607 shares to directors and officers for gross proceeds of about $140,000
Moving iMage Technologies reported fiscal third-quarter 2026 results for the period ended March 31, 2026. Revenue fell 4.9% to $3.39 million, while the net loss narrowed to $122,000, or $0.01 per share, from $240,000, or $0.02 per share, a year earlier. The company expects fourth-quarter revenue of approximately $5.3 million, which would be above the third-quarter level.
Q3 revenue was $3.39 million, down 4.9% from $3.57 million, with $460,000 from DCS cinema loudspeaker sales.
Gross margin rose to 34.8% from 29.8%, and the operating loss narrowed to $134,000 from $270,000.
The company expects Q4 revenue of approximately $5.3 million and a gross margin of 25% to 30%.
At March 31, 2026, cash was $2.4 million, working capital was $4.3 million, and the company reported zero debt.
Toll Brothers reported second-quarter fiscal 2026 results for the three months ended April 30, 2026, with net income of $260.6 million ($2.72 per diluted share), down from $352.4 million ($3.50) a year earlier. Home sales revenues fell to $2.51 billion from $2.71 billion as deliveries declined to 2,491 homes from 2,899. Management said it is raising full-year guidance across its key home building metrics based on year-to-date performance.
Net income $260.6 million, or $2.72 per diluted share, versus $352.4 million, or $3.50, a year earlier
Home sales revenues $2.51 billion on 2,491 deliveries, versus $2.71 billion on 2,899 deliveries
Adjusted home sales gross margin 26.2% versus 27.5%; SG&A at 10.3% of home sales revenues versus 9.5%
Full-year FY 2026 guidance includes 10,400 to 10,700 deliveries and an adjusted home sales gross margin of 26.10%
CAVA reported fiscal first quarter 2026 results for the 16-week period ended April 19, 2026. Revenue rose 32.2% to $434.4 million and same restaurant sales rose 9.7%, but net income fell to $23.6 million from $25.7 million, and diluted EPS was $0.20 versus $0.22. The company raised its fiscal 2026 guidance for same restaurant sales and Adjusted EBITDA.
Revenue of $434.4 million, up 32.2% from $328.5 million a year earlier; same restaurant sales rose 9.7%, including 6.8% guest traffic growth.
Net income of $23.6 million versus $25.7 million; the filing cites a lower tax benefit from equity-based compensation and higher depreciation and amortization.
Adjusted EBITDA of $61.7 million, up 37.6%; the company opened 20 net new restaurants, bringing the total to 459.
Fiscal 2026 guidance raised: same restaurant sales to 4.5% to 6.5% (from 3.0% to 5.0%) and Adjusted EBITDA to $181.0 million to $191.0 million (from $176.0 million to $184.0 million).
Eagle Materials reported fiscal 2026 revenue of $2.3 billion, up 2% and a record, but net earnings fell 9% to $423.8 million and diluted earnings per share fell 4% to $13.16. For the fourth quarter ended March 31, 2026, revenue rose 2% to $479.1 million while net earnings fell 10% to $60.2 million. The filing gives no earnings guidance, and management cited near-term uncertainty in demand.
Fiscal 2026 Light Materials operating earnings fell 15% to $331.4 million, mainly on lower Gypsum Wallboard volume and prices.
Fiscal 2026 Heavy Materials operating earnings rose 10% to $341.2 million, driven by higher Cement and Aggregates sales volume.
Company repurchased about 1.7 million shares for $382 million in fiscal 2026 and reported net debt of $1.5 billion at a 1.9x net leverage ratio.
Home Depot reported first quarter fiscal 2026 sales of $41.8 billion, up 4.8% from a year earlier, with comparable sales up 0.6%. Net earnings fell 4.2% to $3.3 billion, or $3.30 per diluted share, and the company reaffirmed its full-year fiscal 2026 guidance, so shareholders see higher sales alongside lower profit per share.
Sales of $41.8 billion, up $1.9 billion or 4.8%; comparable sales up 0.6%, with U.S. comparable sales up 0.4%
Diluted EPS of $3.30 vs. $3.45 a year earlier; adjusted diluted EPS of $3.43 vs. $3.56
Fiscal 2026 guidance reaffirmed, including diluted EPS growth of approximately flat to 4.0% from $14.23 in fiscal 2025
Operating income of $5.0 billion, down 3.0%; operating margin 11.9% vs. 12.9%
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.